Accure Acne, Inc.
510(k) · clearedClass IIK242035
Cleared2022Studies66Trials5
RevLite — FDA clearance record and published evidence
Cynosure, Inc. · Lasers & Light
510(k) · clearedClass IIK133254
PathwayPathwayA 510(k) clearance means FDA agreed the device is substantially equivalent to a device already legally on the market. It is a clearance, not an approval: it is not a finding that the device is effective, and not a comparison against any other product.
Methodology →510(k) · cleared
Methodology →510(k) · cleared
ClassII
First cleared2006
Years on marketYears on marketDerived: the data run date minus the first matched FDA decision date. Arithmetic on a real date, nothing else.
Methodology →20
Methodology →20
StudiesStudiesPubMed records for a fixed query about the MODALITY, not the brand. It measures how much has been published about a technique. It is not a quality score, not an efficacy measure, not a count of randomised trials, and not comparable between modalities of different ages. It says nothing about this brand specifically.
Methodology →—
Methodology →—
TrialsTrialsClinicalTrials.gov studies for a fixed query about the MODALITY, not the brand. Registration is not completion, not publication and not a result. Counts include studies of any status, size or sponsor, and the recruiting figure is a snapshot taken on the run date. Device studies are under-registered relative to drug studies.
Methodology →—
Methodology →—
A 510(k) device is cleared, not approved — a different route, not a lesser one. What this measuresA 510(k) clearance means FDA agreed the device is substantially equivalent to a device already legally on the market. It is a clearance, not an approval: it is not a finding that the device is effective, and not a comparison against any other product. It measures how much has been published about a technique. It is not a quality score, not an efficacy measure, not a count of randomised trials, and not comparable between modalities of different ages. It says nothing about this brand specifically.
Methodology →
Overview
- Modality
- —
- Manufacturer
- Cynosure, Inc.
- Category
- Lasers & Light
- Latest decision
- FDA records
- 5
- Mapping
- Verified
Mapping is the weakest link on this page; the rule is published. What this measuresMatched 5 openFDA 510(k) record(s) whose device_name contains 'revlite'. Every K-number, product code and date below is copied verbatim from that API response; none is inferred. modality left null: this is a Q-SWITCHED NANOSECOND laser. The existing 'picosecond-laser' modality's PubMed query is picosecond-specific, so assigning it would mis-attribute the evidence. No modality is assigned, so no literature or trial counts are attached to this product. A mapping is the weakest link on this page: if it is wrong, every number above it is about the wrong product. It is stated in full so it can be checked.
Methodology →
Regulatory
| Identifier | Type | Role | FDA record |
|---|---|---|---|
| K133254 | 510(k) — cleared | Primary | Open → |
| K103118 | 510(k) — cleared | — | Open → |
| K083899 | 510(k) — cleared | — | Open → |
| K063834 | 510(k) — cleared | — | Open → |
| K063112 | 510(k) — cleared | — | Open → |
| Code | FDA device name | 21 CFR |
|---|---|---|
| GEX | Powered Laser Surgical Instrument | 878.4810 |
Cleared indication: not transcribed here — read it on K133254 → Cleared indicationopenFDA's release of this database does not return the indications-for-use text, and this Index will not paraphrase a regulatory statement it has not transcribed. A 510(k) clearance means FDA agreed the device is substantially equivalent to a device already legally on the market. It is a clearance, not an approval: it is not a finding that the device is effective, and not a comparison against any other product.
Methodology →
EUDAMEDAlso registered in the EU
- Listed as
- Revlite
- Manufacturer
- Cynosure LLC
- Basic UDI-DI
- B-00841494100216
- UDI-DI
- 00841494100216
- Risk class
- Class IIb
- Status in EUDAMED
- On the market
Open the EUDAMED record → We matched 1 further EUDAMED record for this brand; this is the one shown.
Registered in EUDAMED, the EU device database. A registration, not an approval. What this measuresListed in EUDAMED, the EU medical device database, as of Jul 26 2026. EUDAMED registration became mandatory in May 2026 with a transition period, so devices not listed here may still be CE marked — we show only records we could match. A EUDAMED entry is a registration, not an FDA-style clearance or approval, and says nothing about safety, efficacy or quality. The name and manufacturer shown are spelled exactly as EUDAMED spells them.
Methodology →
Evidence
No modality is assigned to this product, so no literature or trial counts are shown.
Treatment areas
No treatment area could be derived: neither the modality's condition query nor the FDA product codes contained a term on the keyword list.
Sources
- openFDA query run for this producthttps://api.fda.gov/device/510k.json?search=device_name%3A%22RevLite%22&sort=decision_date%3Adesc&limit=100
- openFDA classification record for product code GEXhttps://api.fda.gov/device/classification.json?search=product_code:%22GEX%22&limit=1
- FDA public record for K133254https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K133254
No adverse-event data is published anywhere on this site. What this measuresNo adverse-event data appears anywhere on this site. MAUDE and FAERS were never queried: those counts have no denominator, reporting is voluntary and duplicated, and a report is not evidence of causation. Publishing them beside a brand name would mislead.
Methodology →